Tags : Tetra

Clinical Trials

Tetra Bio-Pharma Initiates Additional Studies of ARDS-003 in Neuroinflammation and

Shots: Tetra and Targeted Pharmaceuticals collaborated with George Mason University NCBID to examine the potential benefits of ARDS-003 in neuroinflammation and other antiviral applications The collaboration with Targeted provides expertise into the areas of drug development to expand the potential Return on Investment of ARDS-003 The agreement will advance the antiviral CNS program, which is […]Read More